Aclaris

Aclaris focuses on identifying, developing, and commercializing novel topical dermatological therapeutics that serve the largest and fastest growing sectors of the dermatology market and that fill unmet medical and aesthetic needs. The Company expects to develop its lead product, A-101, as a medical-professional administered in-office topical therapy for the treatment of seborrheic keratosis. Additionally the Company is pursuing indications which include the treatment of a number of other dermatologic conditions. Our team is also currently evaluating other equally promising dermatologic assets that are in various stages of preclinical & clinical development.